Nanowear
Smarter Care. Anywhere.
Transforming home-based healthcare with end-to-end FDA approved cloth nanotechnology and AI-driven diagnostics.
Our FDA approved, high fidelity digital diagnostic allows for proprietary back-end data ingestion to be matched with an AI-based platform.
Delivering a full cardiometabolic assessment and continuous picture of individualized health, all while the patient is in the comfort of their own home.
Physician and nursing staff empowerment, efficiency, and value-based outcomes with unparalleled patient experience
Nanowear is the new standard for AI based remote diagnostics utilizing proprietary patented cloth-based nanotechnology. Our nanosensors capture 85+ medical grade biomarkers directly from the skin, enabling a closed loop digital system for specific machine-learning algorithms built on terabytes of unique human data.
Nanowear’s first of its kind platform enables a radical leap forward in remote diagnostics and empowering physician decision-making and improving outcomes without the need for physical visits.
Real World Evidence Based Data Driven Insights
Clinical Research Data Services
Nanowear’s FDA-approved platform provides a smarter way for patients to participate in clinical studies at home, saving CRO’s, MedTech, Biotech, and Pharma companies significant direct and indirect costs.
Nanowear provides clinicians with a user-friendly platform to see each of their patient’s metrics integrated into the one location and scored against the same timeline continuously and synchronized. This clinical grade data is streamlined straight to the medical team’s platform, with no manual inputs, and no need for in-person visits: improving clinical trial efficiency, quality, and standardization across geographies, all while collecting data from the real world.
Cardiometabolic Assesments
Nanowear provides a first of its kind cardiometabolic assessment capability: capturing the full symphony of a patient’s heart, lungs, vascular, and hemodynamic systems continuously and time-synchronized, replacing up to eight diagnostic tools in one platform.
Nanowear’s FDA-approved platform digitally records and transfers clinical grade digital diagnostics directly to a patient’s medical team, at the frequency of the prescribing cardiologist’s direction.
Paired with Nanowear’s non-invasive undergarment, the digital diagnostic solution streamlines communication between a patient and their healthcare team. Saving time, reducing the need for in person visits, all while empowering physician decision- making.
Healthcare at Home
Nanowear’s FDA approved, one size fits all, gender neutral, non invasive undergarment collects more than 85 biomarkers per millisecond. The medical team can view the patient’s live clinical grade data on Nanowear’s FDA approved user friendly platform, providing a clear picture of a patient’s individualized health, and enabling the medical team to more efficiently identify, intervene, and prevent harmful conditions. All while the patient remains in the comfort of their own home.
Nanowear’s core technology and cloth-based nanosensors offer infinite application possibilities in digital diagnostics to include but not limited to structural cardiology, heart failure, primary care, sleep apnea, and post surgical recovery.
Our Partners
Awards & Recognition
-
![]()
Nanowear awarded Best Cardiovascular Digital Diagnostic at UCSF Digital Health Awards
The companies awarded were selected across 13 categories by an unmatched team of expert judges in the healthcare and VC industries, including Vinod Khosla (Khosla Ventures), Ursheet Parikh (Mayfield Fund), Blake Wu (NEA), Michael Roizen (Cleveland Clinic), Michael Blum, MD (UCSF), Michael Lesh, MD (UCSF) and Dan Burnett, MD (Theranova) among others. The winners were chosen from more than 500 companies.
-
![]()
Nanowear receives Frost & Sullivan 2018 Visionary Innovation Leader Award
“Frost & Sullivan research shows that Nanowear’s innovative textile captures and transmits millions of skin-based signals to unlock advanced biometric insights in real time. The result offers providers a rich data stream with which to manage complex disease states; at the same, patients receive a comfortable and discreet means of tracking their health. An additional and unique selling point is Nanowear’s full-stack software development and analytics / alert algorithm that exceeds industry norms to provide advanced sensor modalities and raw data analysis ... Overall, Nanowear is a shining star in the medtech start-up arena.”
— Frost & Sullivan: Visionary Innovation Leader Award for Remote Diagnostic Monitoring
-
![]()
Nanowear CEO named to the AdvaMed Accel Board of Directors
The Advanced Medical Technology Association (AdvaMed), is a trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world. AdvaMed’s membership has reached over 400 members and more than 80 employees with a global presence in countries including Europe, India, China, Brazil, and Japan.
-
![]()
Nanowear one of seven medtech companies selected for Google Launchpad Studio
Based in San Francisco, Launchpad Studio is a fully tailored product development acceleration program that matches top ML startups and experts from Silicon Valley with the best of Google - its people, network, and advanced technologies - to help accelerate applied ML and AI innovation. The program's mandate is to support the growth of the ML ecosystem, and to develop product methodologies for ML.
-
![]()
Nanowear crowned 2018 SXSW Pitch Health & Wearables and Best-in-Show Champion
Pinpointing their customers’ pain points is typically the starting point for startups. But just as imperative for many of the 50 companies pitching in ten categories during the tenth annual Dash-presented SXSW Accelerator Pitch Event is making a positive social impact within global communities.
-
![]()
Nanowear named Innovation Champion of the Accenture HealthTech Innovation Challenge
Nanowear received the award for its congestive heart failure (CHF) monitoring device called SimpleSense. It is a non-invasive undergarment solution worn by patients of a CHF-related hospitalization event which captures and transmits CHF data to a cloud-based environment, providing access and updates to medical professionals for assessment of patient health and progress. The award was presented Jan. 8 at the StartUp Health Festival during the 36th annual J.P. Morgan Healthcare Conference in San Francisco.
-
![]()
Nanowear awarded Grand Prize of the 2017 Philips Wearables Challenge
Launched in summer of 2017, the Philips Wearables Challenge called for novel solutions to predict early signs of patient deterioration and prevent hospital readmission. Forty teams from across the country submitted their cutting edge technologies and systems to facilitate early, appropriate interventions.
-
![]()
Nanowear wins 2017 Execution Award at the MedTech Conference
“Nanowear represents what is so great about the medical technology industry: a strong entrepreneurial spirit combined with next-generation innovation with the goal of improving patient care. With receipt of this award, Nanowear is one step closer to bringing their technology to patients and their physicians, and we are excited to have helped move this process forward.”
— Ashley Wittorf, executive director, AdvaMed Accel
